High fragmentation in platelet concentrates impacts the activation, procoagulant, and aggregatory capacity of platelets

References

• Agbani EO, Poole AW. Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis. Blood. 2017;130(20):2171–10. Epub 2017 10 04. doi:10.1182/blood-2017-05-787259.
   PubMed Web of Science ®Google Scholar
• Heemskerk JW, Mattheij NJ, Cosemans JM. Platelet-based coagulation: different populations, different functions. J Thromb Haemost. 2013;11(1):2–16. Epub 2012 10 31. doi:10.1111/jth.12045.
   PubMed Web of Science ®Google Scholar
• Mazepa M, Hoffman M, Monroe D. Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targets. Arterioscler Thromb Vasc Biol. 2013;33(8):1747–1752. Epub 2013 07 19. doi:10.1161/ATVBAHA.113.301790.
   PubMed Web of Science ®Google Scholar
• Escolar G, McCullough J. Platelet in vitro assays: their correspondence with their in vivo hemostatic potential. Transfusion. 2019;59(12):3783–3793. Epub 2019 10 24. doi:10.1111/trf.15559.
   PubMedGoogle Scholar
• Ng MSY, Tung JP, Fraser JF. Platelet storage lesions: what more do we know now? Transfus Med Rev. 2018;32(3):144–154. Epub 2018 05 13. doi:10.1016/j.tmrv.2018.04.001.
   Web of Science ®Google Scholar
• Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem. 1985;260(20):11107–11114. doi:10.1016/S0021-9258(17)39154-8.
   PubMed Web of Science ®Google Scholar
• Remenyi G, Szasz R, Friese P, Dale GL. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler Thromb Vasc Biol. 2005;25(2):467–471. Epub 2004 12 14. doi:10.1161/01.ATV.0000152726.49229.bf.
   PubMed Web of Science ®Google Scholar
• Sodergren AL, Tynngard N, Berlin G, Ramstrom S. Responsiveness of platelets during storage studied with flow cytometry–formation of platelet subpopulations and LAMP-1 as new markers for the platelet storage lesion. Vox Sang. 2016;110(2):116–125. Epub 2015 09 22. doi:10.1111/vox.12324.
   PubMed Web of Science ®Google Scholar
• Sodergren AL, Ramstrom S. Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol. Sci Rep. 2018;8(1):1441. Epub 2018 01 25. doi:10.1038/s41598-017-19126-8.
   PubMedGoogle Scholar
• Tynngard N, Trinks M, Berlin G. In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma-irradiated platelets. Transfusion. 2015;55(6):1169–1177. doi:10.1111/trf.12963.
   PubMed Web of Science ®Google Scholar
• Sandgren P, Berlin G, Tynngard N. Treatment of platelet concentrates with ultraviolet C light for pathogen reduction increases cytokine accumulation. Transfusion. 2016;56(6):1377–1383. Epub 2016 04 16. doi:10.1111/trf.13601.
   PubMed Web of Science ®Google Scholar
• Tynngard N, Wikman A, Uhlin M, Sandgren P. Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet a light. Blood Transfus. 2020;18(3):191–199. Epub 2019 08 14. doi:10.2450/2019.0061-19.
   PubMed Web of Science ®Google Scholar
• Egan K, Dillon A, Dunne E, Kevane B, Galvin Z, Maguire P, Kenny D, Stewart S, Ainle FN. Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation. J Thromb Thrombolysis. 2017;43(1):54–59. Epub 2016 07 16. doi:10.1007/s11239-016-1401-0.
   PubMed Web of Science ®Google Scholar
• Handtke S, Steil L, Greinacher A, Thiele T. Toward the relevance of platelet subpopulations for transfusion medicine. Front Med. 2018;5:17. Epub 2018 02 21. doi:10.3389/fmed.2018.00017.
   PubMed Web of Science ®Google Scholar
• Saunders C, Rowe G, Wilkins K, Holme S, Collins P. In vitro storage characteristics of platelet concentrates suspended in 70% SSP+(TM) additive solution versus plasma over a 14-day storage period. Vox Sang. 2011;101(2):112–121. Epub 2011 03 19. doi:10.1111/j.1423-0410.2011.01468.x.
   PubMed Web of Science ®Google Scholar
• Krailadsiri P, Seghatchian J. Are all leucodepleted platelet concentrates equivalent? Comparison of cobe LRS turbo, haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets. Vox Sang. 2000;78(3):171–175. doi:10.1046/j.1423-0410.2000.7830171.x.
   PubMed Web of Science ®Google Scholar
• Zhang JG, Carter CJ, Culibrk B, Devine DV, Levin E, Scammell K, Weiss S, Gyongyossy-Issa MI. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion. 2008;48(5):847–856. doi:10.1111/j.1537-2995.2008.01645.x.
   PubMed Web of Science ®Google Scholar
• Marcoux G, Duchez AC, Rousseau M, Levesque T, Boudreau LH, Thibault L, Boilard E. Microparticle and mitochondrial release during extended storage of different types of platelet concentrates. Platelets. 2017;28(3):272–280. doi:10.1080/09537104.2016.1218455.
   PubMed Web of Science ®Google Scholar
• Rank A, Nieuwland R, Liebhardt S, Iberer M, Grutzner S, Toth B, Pihusch R. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang. 2011;100(2):179–186. Epub 2010 08 13. doi:10.1111/j.1423-0410.2010.01385.x.
   PubMed Web of Science ®Google Scholar
• Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol. 2006;134(3):307–313. doi:10.1111/j.1365-2141.2006.06167.x.
   PubMed Web of Science ®Google Scholar
• Schoenwaelder SM, Yuan Y, Josefsson EC, White MJ, Yao Y, Mason KD, O’Reilly LA, Henley KJ, Ono A, Hsiao S, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood. 2009;114(3):663–666. Epub 2009 04 24. doi:10.1182/blood-2009-01-200345.
   PubMed Web of Science ®Google Scholar
• Tohidi-Esfahani I, Lee CSM, Liang HPH, Chen VMY. Procoagulant platelets: laboratory detection and clinical significance. Int J Lab Hematol. 2020;42(Suppl 1):59–67. Epub 2020 06 17. doi:10.1111/ijlh.13197.
   PubMedGoogle Scholar
• Vasina EM, Cauwenberghs S, Staudt M, Feijge MA, Weber C, Koenen RR, Heemskerk JW. Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release.Am J Blood Res. 2013;3(2):107–123. Epub 2013 05 16.
   PubMedGoogle Scholar
• Munnix IC, Kuijpers MJ, Auger J, Thomassen CM, Panizzi P, van Zandvoort MA, Rosing J, Bock PE, Watson SP, Heemskerk JW. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol. 2007;27(11):2484–2490. Epub 2007 09 01. doi:10.1161/ATVBAHA.107.151100.
   PubMed Web of Science ®Google Scholar
• Cookson P, Sutherland J, Turner C, Bashir S, Wiltshire M, Hancock V, Smith K, Cardigan R. Platelet apoptosis and activation in platelet concentrates stored for up to 12 days in plasma or additive solution. Transfus Med. 2010;20(6):392–402. Epub 2010 08 27. doi:10.1111/j.1365-3148.2010.01034.x.
   PubMed Web of Science ®Google Scholar
• Leytin V, Allen DJ, Mutlu A, Mykhaylov S, Lyubimov E, Freedman J. Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage. Br J Haematol. 2008;142(3):494–497. Epub 2008 05 22. doi:10.1111/j.1365-2141.2008.07209.x.
   PubMed Web of Science ®Google Scholar
• Ostrowski SR, Bochsen L, Salado-Jimena JA, Ullum H, Reynaerts I, Goodrich RP, Johansson PI. In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion. 2010;50(10):2210–2219. Epub 2010 05 12. doi:10.1111/j.1537-2995.2010.02681.x.
   PubMed Web of Science ®Google Scholar
• Cardigan R, Sutherland J, Garwood M, Bashir S, Turner C, Smith K, Hancock V, Wiltshire M, Pergande C, Williamson LM. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags. Vox Sang. 2008;94(2):103–112. doi:10.1111/j.1423-0410.2007.01008.x.
   PubMed Web of Science ®Google Scholar
• Perales Villarroel JP, Figueredo R, Guan Y, Tomaiuolo M, Karamercan MA, Welsh J, Selak MA, Becker LB, Sims C. Increased platelet storage time is associated with mitochondrial dysfunction and impaired platelet function. J Surg Res. 2013;184(1):422–429. Epub 2013 07 09. doi:10.1016/j.jss.2013.05.097.
   PubMed Web of Science ®Google Scholar
• Picker SM, Schneider V, Oustianskaia L, Gathof BS. Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies. Transfusion. 2009;49(11):2311–2318. Epub 2009 07 25. doi:10.1111/j.1537-2995.2009.02316.x.
   PubMed Web of Science ®Google Scholar
• Verhoeven AJ, Verhaar R, Gouwerok EG, de Korte D. The mitochondrial membrane potential in human platelets: a sensitive parameter for platelet quality. Transfusion. 2005;45(1):82–89. doi:10.1111/j.1537-2995.2005.04023.x.
   PubMed Web of Science ®Google Scholar
• Hosseini E, Mohtashami M, Ghasemzadeh M. Down-regulation of platelet adhesion receptors is a controlling mechanism of thrombosis, while also affecting post-transfusion efficacy of stored platelets. Thromb J. 2019;17(1):20. Epub 2019 10 30. doi:10.1186/s12959-019-0209-5.
   PubMed Web of Science ®Google Scholar
• Hosseini E, Ghasemzadeh M, Nassaji F, Jamaat ZP. GPVI modulation during platelet activation and storage: its expression levels and ectodomain shedding compared to markers of platelet storage lesion. Platelets. 2017;28(5):498–508. Epub 2016 10 26. doi:10.1080/09537104.2016.1235692.
   PubMed Web of Science ®Google Scholar
• Glas M, Bauer JV, Eichler H, Volk T. Impedance aggregometric analysis of platelet function of apheresis platelet concentrates as a function of storage time. Scand J Clin Lab Invest. 2016;76(8):664–670. Epub 2016 10 06. doi:10.1080/00365513.2016.1238505.
   PubMed Web of Science ®Google Scholar
• Ostrowski SR, Bochsen L, Windelov NA, Salado-Jimena JA, Reynaerts I, Goodrich RP, Johansson PI. Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion. 2011;51(2):344–356. Epub 2010 08 21. doi:10.1111/j.1537-2995.2010.02821.x.
   PubMed Web of Science ®Google Scholar
• Shams Hakimi C, Hesse C, Wallen H, Boulund F, Grahn A, Jeppsson A. In vitro assessment of platelet concentrates with multiple electrode aggregometry. Platelets. 2015;26(2):132–137. doi:10.3109/09537104.2014.898141.
   PubMed Web of Science ®Google Scholar
• Singh S, Shams Hakimi C, Jeppsson A, Hesse C. Platelet storage lesion in interim platelet unit concentrates: a comparison with buffy-coat and apheresis concentrates. Transfus Apher Sci. 2017;56(6):870–874. doi:10.1016/j.transci.2017.10.004.
   PubMed Web of Science ®Google Scholar
• Tohidi-Esfahani I, Tan S, Tan CW, Johnson L, Marks DC, Chen VM. Platelet procoagulant potential is reduced in platelet concentrates ex vivo but appears restored following transfusion. Transfusion. 2021;61(12):3420–3431. Epub 2021 10 05. doi:10.1111/trf.16695.
   PubMed Web of Science ®Google Scholar
• Quach ME. Gpib-IX-V and platelet clearance. Platelets. 2022;33(6):817–822. Epub 2021 06 24. doi:10.1080/09537104.2021.1942815.
   PubMed Web of Science ®Google Scholar